These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16518710)

  • 1. Effect of pH on the in vitro activity of and propensity for emergence of resistance to fluoroquinolones, macrolides, and a ketolide.
    Dalhoff A; Schubert S; Ullmann U
    Infection; 2005 Dec; 33 Suppl 2():36-43. PubMed ID: 16518710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones.
    McDonald M; Blondeau JM
    J Cataract Refract Surg; 2010 Sep; 36(9):1588-98. PubMed ID: 20692574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of Garenoxacin against Macrolide-Susceptible and -Resistant Mycoplasma pneumoniae.
    Yamazaki T; Sasaki T; Takahata M
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2278-9. PubMed ID: 17387152
    [No Abstract]   [Full Text] [Related]  

  • 4. Kinetics and quantification of antibacterial effects of beta-lactams, macrolides, and quinolones against gram-positive and gram-negative RTI pathogens.
    Schaper KJ; Schubert S; Dalhoff A
    Infection; 2005 Dec; 33 Suppl 2():3-14. PubMed ID: 16518706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative quantification of the in vitro activity of veterinary fluoroquinolones.
    Grobbel M; Lübke-Becker A; Wieler LH; Froyman R; Friederichs S; Filios S
    Vet Microbiol; 2007 Sep; 124(1-2):73-81. PubMed ID: 17498893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro.
    Anderson R; Steel HC; Cockeran R; von Gottberg A; de Gouveia L; Klugman KP; Mitchell TJ; Feldman C
    J Antimicrob Chemother; 2007 Nov; 60(5):1155-8. PubMed ID: 17848373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolide and ketolide resistance with Streptococcus pneumoniae.
    Doern GV
    Med Clin North Am; 2006 Nov; 90(6):1109-24. PubMed ID: 17116439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections.
    Appelbaum PC
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):5-16. PubMed ID: 19667544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antibacterial activity of novel bifunctional macrolides.
    Akritopoulou-Zanze I; Phelan KM; Marron TG; Yong H; Ma Z; Stone GG; Daly MM; Hensey DM; Nilius AM; Djuric SW
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3809-13. PubMed ID: 15203167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis.
    Athamna A; Athamna M; Medlej B; Bast DJ; Rubinstein E
    J Antimicrob Chemother; 2004 Apr; 53(4):609-15. PubMed ID: 14998982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolide resistance rates in respiratory pathogens in Slovenia following reduced macrolide use.
    Cizman M; Beović B; Seme K; Paragi M; Strumbelj I; Müller-Premru M; Cad-Pecar S; Pokorn M
    Int J Antimicrob Agents; 2006 Dec; 28(6):537-42. PubMed ID: 17101264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS).
    Wierzbowski AK; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2009 Mar; 63(3):620-2. PubMed ID: 19151038
    [No Abstract]   [Full Text] [Related]  

  • 13. A stochastic assessment of the public health risks of the use of macrolide antibiotics in food animals.
    Hurd HS; Malladi S
    Risk Anal; 2008 Jun; 28(3):695-710. PubMed ID: 18643826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activity of PGE 9262932 and fluoroquinolones against Canadian clinical Streptococcus pneumoniae isolates, including molecularly characterized ciprofloxacin-resistant isolates.
    Adam HJ; Schurek KN; Decorby MR; Weshnoweski B; Vashisht R; Karlowsky K; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2006 Jul; 58(1):202-4. PubMed ID: 16636082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values.
    Jones RN; Fritsche TR; Sader HS; Stilwell MG
    Diagn Microbiol Infect Dis; 2007 May; 58(1):9-17. PubMed ID: 17408903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of resistance to fluoroquinolones in clinical and environmental isolates of Pseudomonas aeruginosa.
    Prasad SV; Ballal M; Shivananda PG
    Indian J Pathol Microbiol; 2007 Jan; 50(1):94-6. PubMed ID: 17474274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004).
    Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2007 May; 58(1):27-32. PubMed ID: 17383140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of in vitro-selected mutants of Ureaplasma parvum resistant to macrolides and related antibiotics.
    Pereyre S; Métifiot M; Cazanave C; Renaudin H; Charron A; Bébéar C; Bébéar CM
    Int J Antimicrob Agents; 2007 Feb; 29(2):207-11. PubMed ID: 17196370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic resistance in ocular bacterial pathogens.
    Sharma S
    Indian J Med Microbiol; 2011; 29(3):218-22. PubMed ID: 21860100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.